Bartilet, Keanne Mathew .

HRN: 27-21-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2025
CLOXACILLIN 500MG (CAP)
05/28/2025
06/04/2025
IV
390mg
Q6
T/C Chemical Burn Vs Staphylococcal Scalded Syndrome
Checking Initial Appropriateness 
05/28/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/28/2025
06/04/2025
TOPICAL
0.5mg
TID
T/C Chemical Burn Vs SSSS
Checking Initial Appropriateness 
05/29/2025
MUPIROCIN 2%, 15G (TUBE)
05/29/2025
06/05/2025
TOPICAL
15g
TID
Staphylococcal Infection
Checking Initial Appropriateness 
05/29/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/29/2025
06/04/2025
IV
120mg
Q6h
Chemical Burn Vs SSS
Checking Initial Appropriateness 
06/01/2025
CEFTRIAXONE 1G (VIAL)
06/01/2025
06/07/2025
IV DRIP
1.5g
Q24
T/C Staphylococcal Scalded Skin Syndrome
Remove - Pending Acceptance
06/01/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/01/2025
06/07/2025
TOPICAL
1%
BID
T/C Staphylococcal Scalded Skin Syndrome
Remove - Pending Acceptance
06/01/2025
MUPIROCIN 2%, 15G (TUBE)
06/01/2025
06/07/2025
TOPICAL
2%
BID
T/C Staphylococcal Scalded Skin Syndrome
Remove - Pending Acceptance
06/02/2025
MUPIROCIN 2%, 15G (TUBE)
06/02/2025
06/09/2025
TOPICAL
15g
BID
T/C Staphylococcal Scalded Syndrome
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: